ALLO Competitors & Alternatives

Compare Allogene Therapeutics Inc with similar stocks in the same industry

Biotechnology

ALLO

Main Stock
$2.08
Tradestie Score
55
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+307.9%

Top Competitors

234 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OLMA Olema Pharmaceuticals, Inc. Common Stock
$12.64
$757.72M - 58 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$34.67
$748.90M - 58 Compare
TBPH Theravance Biopharma, Inc.
$16.93
$726.21M 7.6 59 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$23.97
$718.62M - 58 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$30.62
$715.25M - 56 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$146.76
$699.30M - 59 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$7.34
$688.47M - 57 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
ANL ANL
$9.49
$682.62M - 58 Compare

Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)

234 stocks in this industry